Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McGovern

Showing results (11-20 of 275) with videos related to

Pageof 28
Sort By:
Heart Disease (Hagerstown, Md.)|November 27, 2001
Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failureT Chow, J Galvin, B McGovern
Expert Review of Clinical Immunology|March 7, 2012
LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel diseasePuja Vora, Dermot P B McGovern
Journal of Pediatric Surgery|December 1, 1985
A totally implantable venous access system for long-term chemotherapy in childrenB McGovern, R Solenberger, K Reed
Gut|July 13, 2005
Risks and benefits of azathioprine therapyD P B McGovern, D P Jewell
Expert Review of Clinical Immunology|May 10, 2016
Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityByong Duk Ye, Dermot P B McGovern
Inflammatory Bowel Diseases|May 4, 2005
NOD2, not yet: conSteven R Brant, Dermot P B McGovern
Clinical Cardiology|March 1, 1984
Serious adverse effects of amiodaroneB McGovern, H Garan, J N Ruskin
British Medical Journal (Clinical Research Ed.)|April 10, 1982
Sinus arrest during treatment with amiodaroneB McGovern, H Garan, J N Ruskin
British Medical Journal (Clinical Research Ed.)|January 16, 1982
Sinus arrest during treatment with amiodaroneB McGovern, H Garan, J N Ruskin
Gastroenterology|October 13, 2016
Paneth Cell Alterations in the Development and Phenotype of Crohn's DiseaseThaddeus S Stappenbeck, Dermot P B McGovern
Pageof 28

Showing results (11-20 of 275) with videos related to

Sort By:
Pageof 28
Heart Disease (Hagerstown, Md.)|November 27, 2001
Antiarrhythmic drug therapy in patients with renal failure, liver failure, and congestive heart failureT Chow, J Galvin, B McGovern
Expert Review of Clinical Immunology|March 7, 2012
LRRK2 as a negative regulator of NFAT: implications for the pathogenesis of inflammatory bowel diseasePuja Vora, Dermot P B McGovern
Journal of Pediatric Surgery|December 1, 1985
A totally implantable venous access system for long-term chemotherapy in childrenB McGovern, R Solenberger, K Reed
Gut|July 13, 2005
Risks and benefits of azathioprine therapyD P B McGovern, D P Jewell
Expert Review of Clinical Immunology|May 10, 2016
Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utilityByong Duk Ye, Dermot P B McGovern
Inflammatory Bowel Diseases|May 4, 2005
NOD2, not yet: conSteven R Brant, Dermot P B McGovern
Clinical Cardiology|March 1, 1984
Serious adverse effects of amiodaroneB McGovern, H Garan, J N Ruskin
British Medical Journal (Clinical Research Ed.)|April 10, 1982
Sinus arrest during treatment with amiodaroneB McGovern, H Garan, J N Ruskin
British Medical Journal (Clinical Research Ed.)|January 16, 1982
Sinus arrest during treatment with amiodaroneB McGovern, H Garan, J N Ruskin
Gastroenterology|October 13, 2016
Paneth Cell Alterations in the Development and Phenotype of Crohn's DiseaseThaddeus S Stappenbeck, Dermot P B McGovern
Pageof 28